- ABC Regimen ( Azacitidine, Venetoclax and Chidamide) Is Comparable to the "3+7" Regimen in Newly Diagnosed AML: A Real-World Experience from South ChinaWeng, Jianyu; Huang, Xin; Wu, Ping; Deng, Chengxin; Li, Minming; Chen, Xiaomei; Luo, Chengwei; Zeng, Hui; Zhang, Yuming; Wang, Caixia; Deng, Tingfen; Lin, Lie; Huang, Zhenqian; Wu, Bingyi; Wang, Guozheng; Zheng, Runhui; Ye, Xu; Lai, Peilong; Liang, Yang; Tan, Huo; Li, Yangqiu; Du, Xin65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- Prediction Model for Early Recurrence after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with CMML: A Nationwide Representative Multicenter StudyZhou, Jianying; Wang, Song; Niu, Ting; Jiang, Ming; Wang, Shunqing; Wang, Wen; Zhang, Xi; Dong, Yujun; Wan, Dingming; Du, Xin; Wei, Xudong; Zhu, Han; Li, Yuhua; Bi, Kehong; Song, Xianmin; Chen, Yi; Liu, Li; Luo, Yi; Zhou, Yuhong; Li, Xin; Xu, Yajing; Zhang, Yicheng; Liu, Xiaoliang; Yi, Hai; Huang, Xiaobing; Zhu, Zunmin; Yang, Jianmin; Zhou, Fang; Zhang, Xiaohui65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- Hypomethylating Agents As Maintenance Treatment Following Allogeneic Hematopoietic Transplant in Children's Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Single Center StudyRuan, Yongsheng; Xie, Danfeng; Liu, Xuan; Liu, Qiujun; Li, Chunfu; Wu, Xuedong; He, Yuelin; Feng, Xiaoqin63rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, 2021-12-11 To 2021-12-14.
会议论文
Chidamide-Based Pre-Emptive Treatment for High-Risk AML Patients after Hematopoietic Stem Cell Transplantation: A Real-World Experience from Chinese Single-Center
12阅读
